Calypte Biomedical Corp. announced that it has submitted to the Chinese State Drug Administration (SDA) the results of its clinical trials. The trials were performed in support of the Company's application for approval by the Biologics Branch of the SDA. The trials were performed at four sites and generated urine HIV data on over 10,000 Chinese subjects at various levels of risk for HIV infection. The data, which are to be reviewed by the SDA, estimated the sensitivity of the urine test at 100%, and its specificity at 99.95%. This was posted October 08, 2003. Lets' see that's six months. No wonder China and Twiawan are moving fast, now. They been working at this for months and manufacturing is expected to start by April 15, 2004. The future looks better than ever before...
|